000			01988 a2200517 4500
005			20250517214649.0
264		0	_c20191114
008			201911s 0 0 eng d
022			_a1365-2222
024	7		_a10.1111/cea.13169 _2doi
040			_aNLM _beng _cNLM
100	1		_aHesse, L
245	0	0	_aSubcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma. _h[electronic resource]
260			_bClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology _c08 2018
300			_a1035-1049 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Sublingual
650	0	4	_aAllergens _ximmunology
650	0	4	_aAnimals
650	0	4	_aAntibodies, Neutralizing _ximmunology
650	0	4	_aAntibody Specificity _ximmunology
650	0	4	_aAsthma _xdiagnosis
650	0	4	_aBiomarkers
650	0	4	_aCytokines _xmetabolism
650	0	4	_aDesensitization, Immunologic
650	0	4	_aDisease Models, Animal
650	0	4	_aEosinophils _ximmunology
650	0	4	_aFemale
650	0	4	_aImmunoglobulin G _ximmunology
650	0	4	_aInjections, Subcutaneous
650	0	4	_aMice
650	0	4	_aPollen _ximmunology
650	0	4	_aRespiratory Hypersensitivity _xdiagnosis
650	0	4	_aSublingual Immunotherapy
650	0	4	_aTh2 Cells _ximmunology
700	1		_aBrouwer, U
700	1		_aPetersen, A H
700	1		_aGras, R
700	1		_aBosman, L
700	1		_aBrimnes, J
700	1		_aOude Elberink, J N G
700	1		_avan Oosterhout, A J M
700	1		_aNawijn, M C
773	0		_tClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology _gvol. 48 _gno. 8 _gp. 1035-1049
856	4	0	_uhttps://doi.org/10.1111/cea.13169 _zAvailable from publisher's website
999			_c28382971 _d28382971